Paclitaxel
- Product NDC
- 75007-041
- 11-digit product format
- 750070041
- Labeler code
- 75007
- Product ID
- 75007-041_c455b438-d057-4568-a66a-68775a878fdc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Paclitaxel (aibumin-bound)
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Labeler
- Ningbo Shuangcheng Pharmaceutical Co., Ltd
- Application
- ANDA216355
- Marketing category
- ANDA
- Marketing start
- 2025-05-15
- Substance
- PACLITAXEL
- Active strength
- 100 mg/100mg
- Pharmacologic classes
- Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Paclitaxel
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PACLITAXEL | 100 mg/100mg |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | P88XT4IS4D |
| Rxcui | 583214 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 75007-041-01 | Paclitaxel | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 5 |
| 75007-041-01 | Paclitaxel | 100 mg in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 100 | | 5 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 75007-041-01 | 75007004101 | 1 in 1 CARTON | Historical |